|Bid||0.00 x 1800|
|Ask||0.00 x 800|
|Day's range||155.75 - 159.45|
|52-week range||90.14 - 176.64|
|Beta (5Y monthly)||0.64|
|PE ratio (TTM)||45.75|
|Earnings date||04 May 2021 - 10 May 2021|
|Forward dividend & yield||1.00 (0.64%)|
|Ex-dividend date||20 Apr 2021|
|1y target est||188.14|
Zoetis will participate in the Cowen 41st Annual Health Care Conference on Monday, March 1, 2021.
Zoetis Inc. will participate in the Bank of America Securities 2021 Animal Health Summit Virtual Forum on Thursday, Feb. 25, 2021.
Zoetis receives European Commission marketing authorization for Solensia® (frunevetmab), a new therapy for feline osteoarthritis pain.